LNAI vs LPCN

Lunai Bioworks Inc. vs Lipocine Inc. — Valuation Comparison 2026

LNAI

Biotechnology
Lunai Bioworks Inc.
Quality
2.9
out of 10
Value Trap
41
WARN
Price
$3.04
Last close
Models
5/13
Active
VS

LPCN

Biotechnology
Lipocine Inc.
Quality
5.4
out of 10
Value Trap
18
SAFE
Price
$2.26
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType LNAI Fair ValueLNAI Upside LPCN Fair ValueLPCN Upside
Bayesian DCF Intrinsic $0.84 -72.4% $0.94 -58.5%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $4.50 +99.1%
PWERM Option-Based $6.31 +107.4% $2.44 +8.2%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for LNAI vs LPCN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

LNAI vs LPCN — Which Stock Is More Undervalued?

LPCN scores higher with a 5.4/10 quality rating vs LNAI's 2.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Lunai Bioworks Inc. (LNAI) and Lipocine Inc. (LPCN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

LNAI currently trades at $3.04 with a QOC of 2.9/10, while LPCN trades at $2.26 with a QOC of 5.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).